Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

NSE:INDRAMEDCO Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	1,240	861.5	586.2	23.3	436.24
Depreciation & Amortization	394.6	378.4	332.7	318.8	323.55
Other Amortization	6.2	14.3	16.7	14.4	6.14
Loss (Gain) From Sale of Assets	11.7	8.7	57.7	7.1	-
Asset Writedown & Restructuring Costs	-	-	-	-	10.14
Other Operating Activities	-205.2	115.2	-15.8	-72.8	-66.57
Change in Accounts Receivable	138.7	-234.9	259.5	85.3	27.57
Change in Inventory	9.2	15.4	-12.5	33.3	-37.53
Change in Accounts Payable	406.7	286.1	-281.5	-141.3	164.97
Operating Cash Flow	2,002	1,445	943	268.1	864.51
Operating Cash Flow Growth	38.54%	53.20%	251.73%	-68.99%	14.98%
Capital Expenditures	-693.9	-445.8	-294.8	-209.6	-409.18
Other Investing Activities	-890.4	-633.3	-446.3	18.8	7.25
Investing Cash Flow	-1,584	-1,079	-741.1	-190.8	-401.93
Long-Term Debt Repaid	-37.9	-28.3	-25.1	-20.9	-228.49
Total Debt Repaid	-37.9	-28.3	-25.1	-20.9	-228.49
Net Debt Issued (Repaid)	-37.9	-28.3	-25.1	-20.9	-228.49
Common Dividends Paid	-275.4	-228.4	-2.6	-2.4	-178.63
Other Financing Activities	-10.5	-3.7	-6	-8.1	-20.32
Financing Cash Flow	-323.8	-260.4	-33.7	-31.4	-427.44
Net Cash Flow	93.4	105.2	168.2	45.9	35.14
Free Cash Flow	1,308	998.9	648.2	58.5	455.33
Free Cash Flow Growth	30.90%	54.10%	1008.03%	-87.15%	-21.62%
Free Cash Flow Margin	10.51%	9.09%	7.30%	0.95%	5.48%
Free Cash Flow Per Share	14.26	10.90	7.07	0.64	4.97
Cash Interest Paid	10.6	4.6	6.1	8.1	21.14
Cash Income Tax Paid	468.3	98.5	195.1	93.7	155.86
Levered Free Cash Flow	1,139	956.2	606.55	16.31	386.95
Unlevered Free Cash Flow	1,146	959.08	610.36	16.31	394.02
Change in Net Working Capital	-473.3	-310.3	-23.7	155.17	-133.28

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.